Skip to content

Pain Neuroscience Education Delivered During Aerobic Exercise Versus Exercise Alone

Pain Neuroscience Education Delivered During Aerobic Exercise Versus Exercise Alone in Chronic Low Back Pain

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07152171
Acronym
PNE-MOVE
Enrollment
24
Registered
2025-09-03
Start date
2025-08-25
Completion date
2026-01-15
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Keywords

Musculoskeletal Pain, Pain Neuroscience Education, Aerobic Exercise, Physical Therapy, Rehabilitation

Brief summary

Chronic musculoskeletal pain is a common health condition that reduces quality of life and increases disability. Pain neuroscience education (PNE) has shown positive effects on pain perception, beliefs, and function, especially when combined with physical activity. This randomized controlled trial will compare the effectiveness of delivering PNE during aerobic exercise on a cycle ergometer versus aerobic exercise alone in patients with chronic musculoskeletal pain. Participants will be randomly assigned to one of two groups: PNE during aerobic exercise (experimental group), Aerobic exercise alone (control group). Both groups will perform supervised cycling sessions lasting 20-30 minutes at light intensity (Borg CR10 = 3, 40-50% HRmax). The experimental group will simultaneously receive interactive education about pain mechanisms, central sensitization, and self-management strategies, supported by visual aids and metaphors delivered by a therapist during cycling. Outcomes will be measured at baseline and after the intervention, including: Pain intensity (Visual Analog Scale), Pressure pain threshold (algometry), Functional performance (Sit-to-Stand test), Safety and comfort (Likert scale), The study will enroll 24 participants (12 per group). The findings are expected to clarify whether integrating education with exercise provides superior benefits compared to exercise alone, offering an innovative, safe, and cost-effective strategy for managing chronic musculoskeletal pain.

Detailed description

Objective To determine whether PNE delivered during cycling exercise produces greater improvements in pain intensity, pain thresholds, and functional outcomes than aerobic exercise alone. Study Design This is a single-center, randomized controlled trial with two parallel arms (1:1 allocation). A total of 24 participants with chronic low back pain will be recruited from the Hospital Clínico de la Universidad de Chile. Randomization will assign 12 participants to the experimental group and 12 to the control group, using the Randomization software (www.randomization.com). The random sequence will be determined prior to the start of the initial assessments and will only be known to an external research assistant with no access to participant characteristics. The assignment will remain hidden and stored in the cloud until the end of the intervention and the collection of all study data. When a participant enrolls in the study, the external research assistant will inform the therapist of the assigned intervention group. Intervention Experimental group (PNE + exercise): 20-30 minutes of supervised cycling at light intensity (Perceived exertion, Borg CR10 = 3) while receiving interactive PNE. Education covers neurobiology of pain, central sensitization, and self-management, supported by visual aids and metaphors. Control group (exercise alone): 20-30 minutes of supervised cycling at the same intensity (Perceived exertion, Borg CR10 = 3), without educational content. Sample Size and Analysis Based on prior effect sizes, 28 participants (14 per group) provide sufficient power to detect moderate differences. Data will be analyzed with mixed-model ANOVA (time × group) and additional parametric or nonparametric tests as appropriate. Statistical significance is set at p \< 0.05. Ethical Considerations The study is approved by the Ethics Committee of Hospital Clínico de la Universidad de Chile. Participants will provide informed consent before participation. Risks are minimal (fatigue or mild discomfort), while expected benefits include improved pain understanding, reduced pain intensity, and improved function. This study will be conducted in accordance with the Declaration of Helsinki.

Interventions

BEHAVIORALPain Neuroscience Education During Aerobic Exercise

Participants will cycle on an ergometer for 20-30 minutes at light intensity (Borg CR10 = 3; 40-50% HRmax). During cycling, they will receive interactive pain neuroscience education delivered by a therapist, including neurobiology of pain, central sensitization, and self-management strategies. Visual aids and metaphors will be used to facilitate understanding.

BEHAVIORALAerobic Exercise Alone

Participants will perform 20-30 minutes of supervised cycling on an ergometer at light intensity (Borg CR10 = 3; 40-50% HRmax). No educational content will be provided. Sessions will include warm-up, main phase, and cool-down, matched in duration and intensity to the experimental group.

Sponsors

University of Chile
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome assessors will be blinded to group allocation. Participants and care providers cannot be blinded due to the nature of the intervention.

Intervention model description

This is a two-arm, single-center randomized controlled trial with parallel assignment. Participants with chronic low back pain will be randomized (1:1) to receive either pain neuroscience education delivered during aerobic cycling exercise or aerobic exercise alone. Outcome assessors will be blinded to group allocation.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 to 65 years. * Diagnosis of chronic low back pain lasting ≥ 12 weeks. * Baseline pain intensity ≥ 4/10 on the Visual Analog Scale (VAS). * Able to perform light to moderate aerobic exercise * Willing and able to provide informed consent.

Exclusion criteria

* Inability to understand or follow instructions. * Pregnancy. * Active cancer diagnosis. * Neurological disorders affecting the central nervous system (e.g., stroke). * Participation in alternative or concurrent therapies for pain management. * History of major orthopedic trauma or surgery in the last 12 months. * Any medical contraindication to light exercise identified during the medical screening.

Design outcomes

Primary

MeasureTime frameDescription
Change in Pain Intensity (Visual Analog Scale, 0-10)Baseline (pre-session) and immediately post-intervention (within 30 minutes)Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS; 0 = no pain, 10 = worst imaginable pain). The primary endpoint is the change score (post-session minus baseline). Higher scores indicate greater pain.

Secondary

MeasureTime frameDescription
Change in Pressure Pain Threshold (kgf) by AlgometryPressure pain threshold (PPT) will be measured at the most symptomatic lumbar region using a handheld algometer. Pressure is increased at a constant rate until the participant first perceives pain; the value (kgf) is recorded. The outcome is the change sBaseline (pre-session) and immediately post-intervention (within 30 minutes)
Change in Functional Performance (30-Second Sit-to-Stand Test)Participants sit on a standard chair (≈43 cm height) with arms crossed and stand up/sit down as many times as possible in 30 seconds. The total number of full stands is recorded. The outcome is the change in repetitions from baseline.Baseline (pre-session) and immediately post-intervention (within 30 minutes)
Safety and Comfort Ratings (Likert Scales)Immediately post-intervention (within 30 minutes)Participants rate statements such as "I felt physically comfortable during the session" and "The environment felt safe to exercise" on 5-point Likert scales. Higher scores reflect greater perceived safety/comfort.

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026